Ian Hagemann

Nature · 2011–2014

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.

Whom Ian Hagemann trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Douglas G. Altman

Who trusts Ian Hagemann overall

  1. Rakesh K. Jain

Papers from Ian Hagemann's perspective

Ordered by how strongly the researchers Ian Hagemann trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Quantifying heterogeneity in a meta‐analysis (Statistics in Medicine)
  2. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. (New England Journal of Medicine)
  3. Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+ T lymphocytes are prognostic factors of human ovarian cancer (Proceedings of the National Academy of Sciences of the United States of America)
  4. Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. (Proceedings of the National Academy of Sciences of the United States of America)
  5. Systematic reviews of evaluations of prognostic variables (British medical journal)
  6. Consensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions (Annals of the Rheumatic Diseases)
  7. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. (Journal of Clinical Oncology)
  8. How vague is vague? A simulation study of the impact of the use of vague prior distributions in MCMC using WinBUGS
  9. Controlling the risk of spurious findings from meta‐regression (Statistics in Medicine)
  10. Systematic Review and Meta-analysis Supplements for Primary and Secondary Prevention: Mortality in Randomized Trials of Antioxidant

Their papers